Recent findings suggest that enhancing the nutritional intake of individuals with prostate cancer may offer a non-invasive alternative, according to experts. A study conducted across multiple countries revealed that providing prostate cancer patients with supplements rich in vegetables and beneficial bacteria led to a slowdown in the progression of a key prostate cancer indicator found in the blood. This development has the potential to assist patients in managing the emotional burden of living with a slow-growing tumor that may not pose a threat to their health.
Patients with prostate cancer often undergo routine prostate-specific antigen (PSA) blood tests, where elevated levels can signal tumor growth, though not definitively. In a new trial led by Bedfordshire University, men with low-risk tumors were given a supplement consisting of broccoli, turmeric, pomegranate, green tea, ginger, and cranberry. Additionally, half of the participants received a probiotic supplement containing lactobacillus, a beneficial type of bacteria.
Results showed a significant deceleration in PSA progression in both groups, with a more pronounced effect observed in the group receiving the probiotic supplement. This breakthrough paves the way for dietary interventions, particularly beneficial for patients with slow-growing tumors that may not warrant immediate treatment but are closely monitored by the NHS.
Professor Robert Thomas, the lead author of the study and a consultant clinical oncologist, highlighted the importance of dietary interventions in supporting men on active surveillance. He emphasized the potential of such interventions in reducing the need for aggressive treatments like surgery or radiotherapy among individuals with low-risk prostate cancer.
While the UK National Screening Committee rejected the idea of widespread prostate cancer screening for high-risk groups, including those with a family history of the disease and Black men over 50, the debate over the benefits of early detection continues. The committee cited concerns over the potential harms of unnecessary interventions, such as surgery or chemotherapy, based on inaccurate PSA test results.
The reluctance to implement routine PSA testing stems from data showing that a considerable number of men with low-risk prostate cancer opt for treatment over time despite being initially placed on active surveillance. This trend underscores the challenges in balancing the risks and benefits of early detection methods in prostate cancer management.
In light of these insights, further research and long-term monitoring are planned to evaluate the effectiveness of dietary supplements in reducing the need for aggressive treatments among prostate cancer patients.
